Keep asking for nothing and you'll get nothing, stalyon.
TTNP stock has been a waste of money for over a decade.
The shareholders at Guided Therapeutics were expecting a decision in May or June. Some were panicking and selling. Others were posting on the MB that no news must mean bad news. A void of information provides a fertile playground for negative rumors. Patience was wearing thin.
A statement from management was needed and a PR was issued.
Congratulations to GTHP management, that's the way it should be done.
Shareholders should be kept informed.
It's obvious that Bhonsle & Rubin don't give a squat about shareholders.
If BDSI's film is approved, those three will be battling it out for the film market.
Probuphine is the long lasting, abuse proof and diversion proof version of the film.
Do we know if Titan has requested or held any meetings with the FDA?
There has been nothing from the Company since the CRL.
Are they still in business?
How is notifying shareholders that meetings have been held and the Company is encouraged by the meetings or is optimistic that the issues can be resolved strong arming the FDA?
Perhaps the Company has filed a formal appeal of the decision. Shareholders should be informed of that and when a response is expected.
Perhaps the Company is pursuing dispute resolution. Are they at the Office Director level, the Deputy Center Director level or the Center Director level?
Why do you want to be kept in the dark?
Are you a shareholder?
What is wrong with you people?
How can a shareholder make an educated decision if he should hold the stock, sell or buy more without knowing what the F is going on?
Sunil should be getting hundreds of emails daily from shareholders demanding to know what is going on.
stalyon, weak stuff is better than no stuff.
Didn't you claim that you sold and don't even have a horse in the race anymore?
Sunil is giving you more than weak stuff, he is giving you nothing, yet you bailed?
What is a shareholder who is not a pansy to do?
If Probuphine failed in trial such a drop would be justified. Probuphine met the endpoints. AdCom voted overwhelmingly that Probuphine is safe and effective. A few minor issues need to be resolved.
Are you confusing TTNP with APPA? APPA got a CRL for its only pipeline drug and has a market cap of $120M. Other stocks dropped 5% or 10% on a CRL and some even increased in price.
What does caracass know? According to PropThink, it's $131 million!!!!
"Taking an estimated $120M in peak sales of Zerenex in the U.S. and the EU, plus $11M in royalties on peak sales in Japan (13% peak royalty rate), we arrive at a total $131M for Zerenex revenue to KERX under a base case scenario "
That would ban you from posting.
I'm all for that!
It's extremely rare that a stock does well after a reverse split. Usually it's followed by additional reverse splits.
CTIC, GNTA, XOMA: cases in point.
Anybody who got suckered into buying over $2 will rue the day. This is headed back down below $1, hence the reverse split proposal.
"Probuphine has been shown to be effective with an acceptable safety profile in the following clinical studies:
Two six-month, double-blind, placebo-controlled safety and efficacy trials; one of which included an open label, active control (Suboxone).
In both studies, Probuphine demonstrated superiority to placebo implants, and in the second study, established non-inferiority in comparison to Suboxone.
Two six-month, open-label re-treatment safety trials; and
A pharmacokinetic (relative bioavailability) safety study."
Probuphine as as good as Suboxone.
Per the February filing:
NUMBER OF SHARES 5 SOLE VOTING POWER - 7,446,205
BENEFICIALLY 6 SHARED VOTING POWER - 0
OWNED BY EACH 7 SOLE DISPOSITIVE POWER - 7,446,205
REPORTING PERSON 8 SHARED DISPOSITIVE POWER - 0
It looks like the sold over 3 million shares some time between February and June.
With the pps temporarily depressed (until FDA resolution) someone could try to buyout the Company on the cheap. The rights plan bars that from happening.
and you know nothing.